Trial Search Results
PIEB vs CEI for Labor Analgesia: An MLAC Study
Utilizing a 'minimal local analgesic concentration (MLAC) study' design to first determine the relative potency of Programmed Intermittent Epidural Bolus (PIEB) compared to Continuous Epidural Infusion (CEI) and secondly to determine the mechanism to explain the potential PIEB efficacy advantage.
Stanford is currently accepting patients for this trial.
Lead Sponsor:
Stanford University
Collaborator: Manchester University NHS Foundation Trust
Stanford Investigator(s):
Intervention(s):
- Drug: Bupivacaine
- Drug: Sufentanil
Phase:
Phase 4
Eligibility
Inclusion Criteria:
- ASA I & II, Nulliparous and Multiparous, Spontaneous/Induced/Augmented Labor, Early
active labor (cervix <5 cm (if known)), Pain (VPS) > 3, 18-45 years of age
Exclusion Criteria:
- <37 weeks gestation, H/o Cesarean Section, Multiple Gestation, Pre-eclampsia,
Narcotics within 3 hours prior to labor epidural placement, Chronic Pain (as defined
by chronic opiate consumption), Women who are participating in another study that will
impact protocol
Ages Eligible for Study
18 Years - 45 Years
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Aramina Aksamit, RN
512-287-0594
Recruiting